June 1, 2018 / 12:08 PM / 19 days ago

BRIEF-EU Medicines Agency Announces Recommendations For May 2018

June 1 (Reuters) - EU Medicines Agency:

* EU MEDICINES AGENCY RECOMMENDATIONS FOR MAY 2018

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF IONIS PHARMACEUTICALS' DRUG FOR TRANSTHYRETIN AMYLOIDOSIS INOTERSEN

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF AMGEN, NOVARTIS MIGRAINE DRUG ERENUMAB

* EU MEDICINES AGENCY SAYS CHMP RECOMMENDED RESTRICTING USE OF KEYTRUDA AND TECENTRIQ AS FIRST LINE-TREATMENTS FOR UROTHELIAL CANCER

* EU MEDICINES AGENCY SAYS CHMP RECOMMENDED SEVERAL MEASURES TO MINIMISE RISK OF RARE BUT SERIOUS LIVER INJURY WITH ESMYA Source text ID: (bit.ly/2LO4dE5) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below